Quarterly report pursuant to Section 13 or 15(d)

Common Stock Subject to Redemption - Summary of Reconciliation of Common Stock Reflected in the Balance Sheet (Detail)

v3.23.3
Common Stock Subject to Redemption - Summary of Reconciliation of Common Stock Reflected in the Balance Sheet (Detail) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jan. 01, 2022
Schedule of Reconciliation of Common Stock Reflected in the Balance Sheet [Line Items]                  
Accretion of carrying value to redemption value $ 1,050,036 $ 676,567 $ 2,374,093 $ 796,360 $ 63,680 $ 4,100,696 $ 860,040    
Contingently redeemable common stock 60,926,032         60,926,032   $ 239,285,445  
Common Stock [Member]                  
Schedule of Reconciliation of Common Stock Reflected in the Balance Sheet [Line Items]                  
Accretion of carrying value to redemption value           2,980,696      
Accretion to redemption value from earnings               2,385,445  
Accretion to redemption value from additional funding           1,120,000   2,300,000  
Redemptions           (182,460,109)      
Contingently redeemable common stock $ 60,926,032         $ 60,926,032   $ 239,285,445 $ 234,600,000